Numiera Therapeutics Announces Orphan Drug Designation and Matching Funds from the State of Colorado to Advance Innovative Brain Cancer Treatment Numiera Therapeutics, an Innosphere client company and pharmaceutical pioneer in small-molecule drugs for oncology, is proud to announce two major milestones: its lead candidate has received Orphan Drug Designation from [...]

OncoBLAZE LLC Awarded NSF STTR Phase I Grant to Advance Groundbreaking Precision Chemotherapy Technology OncoBLAZE LLC, an innovative startup from the Medical University of South Carolina, has been awarded $275,000   Phase I Small Business Technology Transfer (STTR) grant by the National Science Foundation (NSF). This grant will support the development [...]

GelSana, an Innosphere Ventures client company, today announced that Diana Verrilli, Chief Growth Officer at DispatchHealth, will join the Company’s Board of Directors. Diana, an accomplished healthcare leader brings extensive experience in commercialization and business strategy planning and execution. “GelSana is very fortunate to have Diana join our Board,” said [...]

Jura Health Welcomed by Colorado Medicaid as an Approved Provider for Testing for Suspected Rare Diseases Denver, CO — Jura Health, an Innosphere Ventures client company, committed to health equity for rare disease patients and their families, is pleased to announce that its offerings are now approved for payment by [...]

GelSana Hires Chief Operating Officer, Jon Fernandez, to Drive Commercialization and Operations Growth GelSana, an Innosphere Ventures client company, today announced it has hired Jon Fernandez as Chief Operation Officer. Jon brings a wealth of experience in both product development, including in wound healing, as well as product commercialization. He [...]